Tiger Pharmaceuticals (03347): Fangda Holdings temporarily suspended trading from October 22, pending publication of inside information

Zhitongcaijing · 3d ago

Zhitong Finance App News, Tiger Pharmaceuticals (03347) issued an announcement. The company noticed that the shares of Fangda Holdings (01521.HK), a subsidiary of the company, had briefly stopped trading on the Hong Kong Stock Exchange Limited at 9:00 a.m. on October 22, 2026, pending Fangda Holdings issuing an announcement containing inside information about Fangda Holdings in accordance with the company's takeover and merger rules.